By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Janssen Pharmaceutical Inc.  

1125 Trenton-Harbourton Road

Titusville  New Jersey  08560  U.S.A.
Phone: 609-730-2000 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Janssen Pharmaceutical Inc. Seeks Expanded Label For Once-Monthly INVEGA® SUSTENNA® (paliperidone palmitate) To Show Delayed Time To Relapse Compared To Daily Oral Schizophrenia Therapies 7/14/2014 9:41:40 AM
GlycoVaxyn AG Announces The Initiation Of A Phase I Clinical Trial In Collaboration With Janssen Pharmaceutical Inc. For A Vaccine Against Extra-Intestinal Pathogenic Escherichia Coli Causing Urinary Tract Infection 7/1/2014 9:58:53 AM
Johnson & Johnson (JNJ)'s Janssen Pharmaceutical Inc. Strikes Influenza A Deal With Vertex Pharmaceuticals (MA) (VRTX) 6/18/2014 7:12:44 AM
Janssen Pharmaceutical Inc. Release: IMAAGEN Data Demonstrate That Abiraterone Acetate Plus Prednisone (5mg Once Daily) Lowers PSA Levels In Men With High-Risk Non-Metastatic Castration-Resistant Prostate Cancer (M0-CRPC) 6/2/2014 9:49:52 AM
Janssen Pharmaceutical Inc. Release: Ibrutinib (IMBRUVICA®) Three Year Follow-Up Of Single-Agent And Combination Study Results In Chronic Lymphocytic Leukemia 6/2/2014 9:11:24 AM
Janssen Pharmaceutical Inc. 's Ibrutinib Triples Progression-Free Survival, Doubles Overall Survival In Phase 3 Leukemia Study 6/2/2014 6:43:32 AM
Janssen Inc.'s First-In-Class Type 2 Diabetes Medication Approved In Canada 5/27/2014 6:51:02 AM
Janssen Pharmaceutical Inc. Release: Supplemental New Drug Applications For Once-Monthly Long-Acting Therapy INVEGA® SUSTENNA® (Paliperidone Palmitate) Submitted To The FDA For The Treatment Of Schizoaffective Disorder 5/13/2014 9:39:36 AM
Janssen Pharmaceutical Inc. Release: Landmark Study Shows Once-Monthly Long-Acting Therapy INVEGA® SUSTENNA® (Paliperidone Palmitate) Significantly Delayed Time To Relapse In Patients With Schizophrenia Compared To Daily Oral Antipsychotics 5/5/2014 7:58:21 AM
Janssen Pharmaceutical Inc. Announces Key Research Presentations At 167th Annual Meeting Of The American Psychiatric Association 4/22/2014 7:15:10 AM
12
//-->